Skip to content
Shuttingdown

Forte Biosciences, Inc.

Pharmaceutical Preparations · DALLAS

No longer listed

High confidence (85%)

Updated Oct 17, 2026, 12:03 AM

What is happening

Derived by rule set status-rules-2026.09.7

The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.

Latest material event: Forte Biosciences, Inc. deregistered its securities (Sep 8, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. Forte Biosciences, Inc. deregistered its securities

    Sep 8, 2026

    Registration withdrawn

    • SEC EDGAR — “15-12G 1 ef20081745_1512g.htm 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 15   CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.   Commission File Number 001-38052   Forte Biosciences, Inc. (Exact name of registrant as specified in its charter)   3060 Pegasus Park Drive, Building 6 Dallas, Texas 75247 (310) 618-6994 (Address, including zip code, and telephone…”

  2. Forte Biosciences, Inc. deregistered its securities

    Sep 8, 2026

    Registration withdrawn

    • SEC EDGAR — “15-12G 1 ef20081742_1512g.htm 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 15   CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.   Commission File Number 001-38052   Forte Biosciences, Inc. (Exact name of registrant as specified in its charter)   3060 Pegasus Park Drive, Building 6 Dallas, Texas 75247 (310) 618-6994 (Address, including zip code, and telephone…”

  3. Forte Biosciences, Inc. deregistered its securities

    Sep 8, 2026

    Registration withdrawn

    • SEC EDGAR — “15-12G 1 ef20081744_1512g.htm 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 15   CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.   Commission File Number 001-38052   Forte Biosciences, Inc. (Exact name of registrant as specified in its charter)   3060 Pegasus Park Drive, Building 6 Dallas, Texas 75247 (310) 618-6994 (Address, including zip code, and telephone…”

  4. Forte Biosciences, Inc. received a delisting notice from its exchange

    Aug 27, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The information set forth in the Introductory Note and Item 2.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.01. In connection with the consummation of the Transactions, the Company notified Nasdaq Stock Market LLC ( NASDAQ ) of the consummation of the Merger and requested that NASDAQ suspend trading of Shares and file with the SEC a Form 25 Notification of Removal from Listing and/or Registration to delist and deregister Shares under Section 12(b…”

  5. Forte Biosciences, Inc. was delisted from its exchange

    Aug 27, 2026

    Delisting effective

    • SEC EDGAR — “X0203 0001354457 Nasdaq Stock Market LLC 0001419041 Forte Biosciences, Inc. 001-38052 3060 Pegasus Park Dr., Building 6 Dallas TX TEXAS 75247 (310) 618-6994 Common Stock 17 CFR 240.12d2-2(a)(3) Tara Petta AVP 2026-08-27”

Company information

Founded
—
Employees (estimate)
—
Industry
Pharmaceutical Preparations
Subindustry
—
Listing
SEC lists the ticker FBRX on Nasdaq.
SEC CIK
0001419041
Website
—
LinkedIn
—
Headquarters
DALLAS
Also known as
Tocagen Inc
Legal entities
Forte Biosciences, Inc.

Sources

Every material source used to build this profile.

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    15-12G 1 ef20081744_1512g.htm 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 15   CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.   Commission File Number 001-38052   Forte Biosciences, Inc. (Exact name of registrant as specified in its charter)   3060 Pegasus Park Drive, Building 6 Dallas, Texas 75247 (310) 618-6994 (Address, including zip code, and telephone…
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    15-12G 1 ef20081742_1512g.htm 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 15   CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.   Commission File Number 001-38052   Forte Biosciences, Inc. (Exact name of registrant as specified in its charter)   3060 Pegasus Park Drive, Building 6 Dallas, Texas 75247 (310) 618-6994 (Address, including zip code, and telephone…
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    15-12G 1 ef20081745_1512g.htm 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 15   CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.   Commission File Number 001-38052   Forte Biosciences, Inc. (Exact name of registrant as specified in its charter)   3060 Pegasus Park Drive, Building 6 Dallas, Texas 75247 (310) 618-6994 (Address, including zip code, and telephone…
    View source record

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    Forte Biosciences, Inc. — Pharmaceutical Preparations (SIC 2834) — DALLAS, TX
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    X0203 0001354457 Nasdaq Stock Market LLC 0001419041 Forte Biosciences, Inc. 001-38052 3060 Pegasus Park Dr., Building 6 Dallas TX TEXAS 75247 (310) 618-6994 Common Stock 17 CFR 240.12d2-2(a)(3) Tara Petta AVP 2026-08-27
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The information set forth in the Introductory Note and Item 2.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.01. In connection with the consummation of the Transactions, the Company notified Nasdaq Stock Market LLC ( NASDAQ ) of the consummation of the Merger and requested that NASDAQ suspend trading of Shares and file with the SEC a Form 25 Notification of Removal from Listing and/or Registration to delist and deregister Shares under Section 12(b…
    View source record

Status history

Every derived status, with the rule that produced it.

  • NO_LONGER_LISTED → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 20, 2026, 12:14 AM

    The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.

  • NO_LONGER_LISTED → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 20, 2026, 12:14 AM

    The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.

  • DISTRESS_SIGNAL → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 18, 2026, 01:32 AM

    The company stopped being publicly listed. A listing ends on the close of a merger as surely as it ends in failure, and the filing does not say which happened here.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:14 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:35 PM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:46 PM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:37 AM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:36 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.